Howard Marks - Oaktree Capital Management
Holding/activity history for Indivior Pharmaceuticals, Inc. (INDV)
← All INDV superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 6,984,102 | 4.94 | Reduce 1.75% | 0.10 | $27.68–37.66 · VW $32.62i | $212,875,428 | SEC |
| 2025 Q4 | 7,108,644 | 5.62 | Reduce 97.24% | 0.22 | $22.56–38.00 · VW $32.55i | $255,058,964 | SEC |
| 2025 Q3 | 257,785,398 | 0.23 | Add 2241.56% | 0.22 | $14.52–25.10 · VW $21.40i | $10,692,053 | SEC |
| 2025 Q2 | 11,009,125 | 4.11 | $14.74 | $162,274,503 | SEC | ||
| 2025 Q1 | 11,009,125 | 2.56 | Add 26.06% | 0.53 | $7.62–12.72 · VW $10.22i | $103,450,915 | SEC |
| 2024 Q4 | 8,733,548 | 2.50 | Reduce 8.28% | 0.15 | $7.33–12.75 · VW $10.47i | $112,004,050 | SEC |
| 2024 Q3 | 9,521,980 | 1.77 | Add 111.92% | 0.93 | $9.05–15.91 · VW $12.04i | $94,068,047 | SEC |
| 2024 Q2 | 4,493,173 | 1.34 | Add 34.08% | 0.34 | $15.71–22.53 · VW $18.14i | $70,429,767 | SEC |
| 2024 Q1 | 3,351,236 | 1.26 | Buy | 1.26 | $15.00–23.22 · VW $19.99i | $71,714,624 | SEC |
Price snapshot:
Current price$40.21
Avg. buy price$0.62
+/- since buy6,418.28%
52-week low$15.00
52-week high$42.81